Sale of GenCell BioSystems Ltd. to Becton, Dickinson & Company
GenCell BioSystems Ltd. ("GenCell BioSystems") is an innovative lifesciences technology company. Its CLiC system fully automates library preparation for next-generation DNA sequencing using proprietary composite liquid cell technology.
The technology has multiple applications across drug discovery, agricultural biotechnology, medical genomics, molecular diagnostics and synthetic biology. Pegasus Capital advised on the sale of the company to US-based Becton Dickinson & Co. a major global healthcare and lifesciences leader. The sale will enable GenCell BioSystems to commercialise its technology on a global basis under the Becton Dickinson & Co. umbrella.
TERMS: EUR 135,000,000